A dose-ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplasty - Fuji, T; Fujita, S; Tachibana, S; Kawai, Y (J Thromb Haemost, 2010)